Posted by LLS Health Technical Team | 10/12/2020
Oral health is an integral part of consumers' mounting desire to lead healthier lifestyles, resulting in industry growth. Increased awareness of oral health coupled with an improved understanding of the underlying causes of oral issues also contribute to the surge; rising market penetration and the growing availability of innovative and differentiated products play a role as well.
Posted by LLS Health Technical Team | 09/16/2020
An aging population, rise in digital screen time, and surge in airborne pollution have increased the incidence of eye disease. These factors have positioned the industry for immense growth as it rises to meet the mounting need. We are witnessing much of this growth now, with two ocular drug approvals already in the first half of 2020. Additionally, there are at least nine other ocular products set to achieve major milestones this year - in this post, the Health team at Lubrizol Life Science (LLS Health) reviews these milestones and their implications.
Posted by LLS Health Technical Team | 08/20/2020
The appropriate selection of component materials is often very important in the development and sustainability of a medical device. For many devices, that selection often begins with a designer’s consideration of a range of known medical polymers.
Posted by LLS Health Technical Team | 08/13/2020
OTC medicines treat and alleviate the symptoms of many common ailments, such as pain, cold and flu, heartburn, and acne. Product examples include cough suppressants, analgesics (pain relievers), and antihistamines. In this post, Lubrizol Life Science Health (LLS Health) dives further into OTC classification, trends in the space, and the market outlook.
Posted by LLS Health Technical Team | 06/16/2020
Oral drug administration is critical for the delivery of drugs in various therapeutic areas, such as cardiovascular and pain management. It is considered the preferred route of administration due to its significant advantages, including being both painless and convenient.
Posted by LLS Health Technical Team | 05/27/2020
The inherent structure and physiology of the eye make it difficult for drugs to reach the site of action and persist over time. Despite these constraints, ocular therapies continue to garner significant interest due to growing patient need. Drug product developers are actively seeking options for overcoming these barriers and effectively delivering ophthalmic drugs.
Posted by LLS Health Technical Team | 05/04/2020
The current regulatory landscape, or lack of an independent excipient approval pathway, may be limiting the entrance of new excipients in the market and, subsequently, new drug products. We sat down with the Director of Regulatory Strategy and Policy for Lubrizol Life Science Health (LLS Health), Meera Raghuram, to discuss the importance of novel excipients and recent actions taken by the FDA.
Welcome to the Blog. Our mission is to accelerate your success through partnership and proactive innovation. This blog will provide unique perspectives from the best in the business. We are dedicated to sharing our extensive market knowledge and formulation expertise to help our partners improve patient outcomes.
